To enroll in 1 month Online Certification in Autism & ADHD Reversal (C.A.A.R) course, Click Here...

1. 1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea. Biomark Res. 2025 Sep 26;13(1):114.

2.  Projected Lifetime Cancer Risks From Current Computed Tomography Imaging. JAMA Intern Med. 2025;185(6):710–719. 

3.  Occupational radiation exposure and risk of thyroid cancer: A meta‑analysis of cohort studies. Oncol Lett. 2024 Jul 15;28(3):437.

Rabbit Tortoise Model for Cancer Cure- Book

Book cover of “Rabbit-Tortoise Model for Cancer Cure” by Dr. Biswaroop Roy Chowdhury, presenting an evidence-based strategy and insights into the cancer industry.
Download Click Here
Testing Cancer Blood Test

CA-19-9 Test For Evidences

CLICK HERE

CA-125 Test for Cancer Diagnosis For Evidences

CLICK HERE

Curing Cancer with Medical Engineering

 5th April 2025, Maheshwari Public School, Jaipur, Rajasthan

Press -Conference

Press -Conference Conquering Cancer- Training &Testimonial

18th March 2025

Medical Reports of the Cancer Patients Presented
during Press conference on 18th March 2025

The Pandemic/Cancer Calendar

Pandemic-Calendar-2025
CLICK HERE
blank calendar
CLICK HERE

Cancer की Deewaar

गुटका, Cigarette, Chemotherapy और Radiation से Cancer होता है

The Pandemic/Cancer Calendar

REFERENCES

No Pathological difference between Normal Cell and Cancer Cell

  • Weis, p.: some introductory remarks on the cellular basis of differentiation. jour embyyolic and exp. morphology, 1:181 ,1953

  • Henderson, E.S.: Acute lymphoblastic leukemia. In, Cancer Medicine, (Ed Holland., and Frei, III, E.), Lea and Febiger, Philadelphia 1974, p.1174

  • Tashima, C.K.: care of the patient, N.Eng. Jour. Med., 295:1435,1976

  • Clarkson, B.D.: Current concepts of Leukemia and results of recent treatment programs. Transplantation Proceedings, 10:157, 1978

    • Spontaneous Regression of Cancer in the absence of Chemotherapy/Radiation/Surgery

  • LARSEN SU, ROSE C. SPONTANEOUS REMISSION OF BREAST CANCER. A LITERATURE REVIEW]. UGESKR LAEG. 1999;161(26):4001-4.

  • MONZEN Y, NAKAHARA M, NISHISAKA T. SPONTANEOUS REGRESSION OF PRIMARY MALIGNANT LYMPHOMA OF THE PROSTATE. CASE REP UROL. 2013;2013:363072

  • BANIHANI MN, AL MANASRA AR. SPONTANEOUS REGRESSION IN ALVEOLAR SOFT PART SARCOMA: CASE REPORT AND LITERATURE REVIEW. WORLD J SURG ONCOL. 2009;7:53.

  • ΤΑΝΑΚΑ K, HAMADA T, TAKASAKI H, YOKOYAMA S. SPONTANEOUS REGRESSION OF MEDIASTINAL SEMINOMA. OAL 1989.

  • PRINTZ C. SPONTANEOUS REGRESSION OF MELANOMA MAY OFFER INSIGHT INTO CANCER IMMUNOLOGY. J NAT CAN INST. 2001; 93 (14): 1047-1048.

  • PAPAC RJ. SPONTANEOUS REGRESSION OF CANCER: POSSIBLE MECHANISMS. IN VIVO. 1998;12(6):571-8.

  • OGAWA D, UEMURA N, SASAKI N, ET AL. SPONTANEOUS REGRESSION OF MALIGNANT LYMPHOMA OF THE STOMACH. J MED. 1998;29(5-6):381-93.

  • BIR AS, FORA AA, LEVEA C, FAKIH MG. SPONTANEOUS REGRESSION OF COLORECTAL CANCER METASTATIC TO RETROPERITONEAL LYMPH NODES. ANTICANCER RES. 2009;29(2):465-8.

  • STEFANI C, LIVERANI CA, BIANCO V, ET AL. SPONTANEOUS REGRESSION OF LOW-GRADE CERVICAL INTRAEPITHELIAL LESIONS IS POSITIVELY IMPROVED BY TOPICAL BOVINE COLOSTRUM PREPARATIONS (GINEDIE). A MULTICENTRE, OBSERVATIONAL, ITALIAN PILOT STUDY. EUR REV MED PHARMACOL SCI. 2014;18(5):728-33.

  • IWANAGA T. (STUDIES ON CASES OF SPONTANEOUS REGRESSION OF CANCER IN JAPAN IN 2011, AND OF HEPATIC CARCINOMA, LUNG CANCER AND PULMONARY METASTASES IN THE WORLD BETWEEN 2006 AND 2011]. GAN TO KAGAKU RYOHO. 2013;40(11):1475-87.

  • DAVIS T, DOYLE H, TOBIAS V, ELLISON DW, ZIEGLER DS. CASE REPORT OF SPONTANEOUS RESOLUTION OF A CONGENITAL GLIOBLASTOMA. PEDIATRICS. 2016;137(4).

  • ISOBE Y, ARITAKA N, SASAKI M, OSHIMI K, SUGIMOTO K. SPONTANEOUS REGRESSION OF NATURAL KILLER CELL LYMPHOMA. J CLIN PATHOL. 2009;62(7):647-50.

    CRISCI A, CORSALE I, ABRAMI F, ET AL. (SPONTANEOUS REGRESSION OF LUNG METASTASES FROM RENAL CELL CARCINOMA: THE IMPORTANCE OF IMMUNOGENETIC FACTORS AND A REVIEW OF THE LITERATURE). MINERVA UROL NEFROL. 2008;60(2):123-35.

  • BIR AS, FORA AA, LEVEA C, FAKIH MG. SPONTANEOUS REGRESSION OF COLORECTAL CANCER METASTATIC TO RETROPERITONEAL LYMPH NODES. ANTICANCER RES. 2009;29(2):465-8.

  • PAREDES BE [REGRESSION IN MALIGNANT MELANOMA, DEFINITION, ETIOPATHOGENESIS, MORPHOLOGY AND DIFFERENTIAL DIAGNOSIS). PATHOLOGE. 2007;28(6):453-63.

  • KHAR A, MURALIKRISHNA K, VARALAKSHMI C. HIGH INTRATUMOURAL LEVEL OF CYTOKINES MEDIATES EFFICIENT REGRESSION OF A RAT HISTIOCYTOMA. CLIN EXP IMMUNOL. 1997;110(1):127- 31.

  • WONG DA, BISHOP GA, LOWES MA, COOKE B, BARNETSON RS, HALLIDAY GM, CYTOKINE PROFILES IN SPONTANEOUSLY REGRESSING BASAL CELL CARCINOMAS. BR J DERMATOL. 2000;143(1):91-8

  • MUELLER N. OVERVIEW OF THE EPIDEMIOLOGY OF MALIGNANCY IN IMMUNE DEFICIENCY. J ACQUIR IMMUNE DEFIC SYNDR. 1999;21 SUPPL 1:55-10.

  • SALEH F, RENNO W, KLEPACEK 1, ET AL. DIRECT EVIDENCE ON THE IMMUNE-MEDIATED SPONTANEOUS REGRESSION OF HUMAN CANCER: AN INCENTIVE FOR PHARMACEUTICAL COMPANIES TO DEVELOP A NOVEL ANTI-CANCER VACCINE. CURR PHARM DES. 2005;11(27):3531-43.

  • SCHILDER H. DE VRIES MJ, GOODKIN K, ANTONI M. PSYCHOLOGICAL CHANGES PRECEDING SPONTANEOUS REMISSION OF CANCER. CLINICAL CASE STUDIES. 2004; 3(4):288-312.

  • OLIVER RT, NETHERSELL AB, BOTTOMLEY JM. UNEXPLAINED SPONTANEOUS REGRESSION AND ALPHA-INTERFERON AS TREATMENT FOR METASTATIC RENAL CARCINOMA. BR J UROL. 1989;63(2):128-31.

  • SROUJIEH AS. SPONTANEOUS REGRESSION OF INTESTINAL MALIGNANT MELANΟΜΑ FROM AN OCCULT PRIMARY SITE, CANCER. 1988;62(6):1247-50.

  • DROBYSKI WR, QAZI R. SPONTANEOUS REGRESSION IN NON-HODGKIN'S LYMPHOMA: CLINICAL AND PATHOGENETIC CONSIDERATIONS. AM J HEMATOL. 1989;31(2):138-41.

  • HORNING SJ, ROSENBERG SA, THE NATURAL HISTORY OF INITIALLY UNTREATED LOW- GRADE NON-HODGKIN'S LYMPHOMAS. N ENGL J MED. 1984;311(23):1471-5.

  • ZAHL PH, MAEHLEN J, WELCH HG. THE NATURAL HISTORY OF INVASIVE BREAST CANCERS DETECTED BY SCREENING MAMMOGRAPHY. ARCH INTERN MED. 2008;168(21):2311-6.

  • BARNETSON RS, HALLIDAY GM. REGRESSION IN SKIN TUMOURS: A COMMON PHENOMENON, AUSTRALAS J DERMATOL. 1997;38 SUPPL 1:S63-5.

  • ZAHL PH, GØTZSCHE PC, MÆHLEN J. NATURAL HISTORY OF BREAST CANCERS DETECTED IN THE SWEDISH MAMMOGRAPHY SCREENING PROGRAMME: A COHORT STUDY. LANCET ONCOL. 2011;12(12):1118-24.

  • FOX MS. ON THE DIAGNOSIS AND TREATMENT OF BREAST CANCER. JAMA. 1979;241(5):489-494

    • Surgery Causes Cancer

  • TEN- YEAR RESULTS OF A COMPARISON OF CONSERVATION WITH MASTECTOMY IN THE TREATMENT OF STAGE I AND II BREAST CANCER. N ENGL J MED. 1995;332(14):907-11.

  • RADICAL PROSTATECTOMY VERSUS OBSERVATION FOR LOCALIZED PROSTATE CANCER. NENGL J MED. 2012;367(3):203-13.

  • OVERALL SURVIVAL ACCORDING TO TYPE OF SURGERY IN YOUNG (≤40 YEARS) EARLY BREAST CANCER PATIENTS: A SYSTEMATIC META-ANALYSIS COMPARING BREAST- CONSERVING SURGERY VERSUS MASTECTOMY. BREAST. 2015;24(3):175-81.

  • PETERS E, MENDOZA SCHULZ L, REUSS-BORST M. QUALITY OF LIFE AFTER CANCER-HOW THE EXTENT OF IMPAIRMENT IS INFLUENCED BY PATIENT CHARACTERISTICS. BMC CANCER. 2016;16(1):787.

  • Langley RR, Fidler IJ. Tumor cell-organ micro environment interactions in the pathogenesis of cancer metastasis. Endocr Rev. 2007;28(3):297-321.

  • Langley RR, Fidler IJ. The seed and soil hypothesis revisited–the role of tumor stroma interactions in metastasis to different organs. Int J Cancer. 2011;128(11):2527-35.

  • Chen LL, Blumm N, Christakis NA, Barabási AL, Deisboeck TS. Cancer metastasis networks and the prediction of progression patterns. Br J Cancer. 2009;101(5):749-58.

    • Chemotherapy causes Cancer

  • POWLES TJ, COOMBES RC, SMITH IE, JONES JM, FORD HT, GAZET JC. FAILURE OF CHEMOTHERAPY TO PROLONG SURVIVAL IN A GROUP OF PATIENTS WITH METASTATIC BREAST CANCER. LANCET. 1980;1(8168 PT 1):580-2.

  • ABEL, ULRICH, PHD "CYTOSTATIC THERAPY OF ADVANCED EPITHELIAL TUMORS A CRITIQUE" LANCET 10 AUG 1991.

  • MORGAN G, WARD R, BARTON M. THE CONTRIBUTION OF CYTOTOXIC CHEMOTHERAPY TO 5-YEAR SURVIVAL IN ADULT MALIGNANCIES. CLIN ONCOL (R COLL RADIOL). 2004;16(8):549-60.

  • MARKSTEIN M, DETTORRE S, CHO J, NEUMÜLLER RA, CRAIG-MÜLLER S, PERRIMON N. SYSTEMATIC SCREEN OF CHEMOTHERAPEUTICS IN DROSOPHILA STEM CELL TUMORS. PROC NATL ACAD SCI USA. 2014;111(12):4530-5.

  • WALLINGTON M, SAXON EB, BOMB M, ET AL. 30-DAY MORTALITY AFTER SYSTEMIC ANTICANCER TREATMENT FOR BREAST AND LUNG CANCER IN ENGLAND: A POPULATION-BASED, OBSERVATIONAL STUDY. LANCET ONCOL. 2016;17(9):1203-16.

  • MOUNTZIOS G, ARAVANTINOS G, ALEXOPOULOU Z, ET AL. LESSONS FROM THE PAST: LONG- TERM SAFETY AND SURVIVAL OUTCOMES OF A PREMATURELY TERMINATED RANDOMIZED CONTROLLED TRIAL ON PROPHYLACT VS. HEMOGLOBIN-BASED ADMINISTRATION ERYTHROPOIESIS-STIMULATING AGENTS PATIENTS WITH CHEMOTHERAPY-INDUC ΑΝΕΜΙΑ. ΜOL CLIN ONCOL. 2016;4(2):211-2

  • FARSI DJ. CHILDREN UNDERGOING CHEMOTHERAPY: IS IT TOO LATE FOR DENTAL REHABILITATION? J CLIN PEDIATR DENT. 2016;40(6):503-505.

  • ABALO R, URANGA JA, PÉREZ-GARCÍA I, ET AL. MAY CANNABINOIDS PREVENT THE DEVELOPMENT OF CHEMOTHERAPY-INDUCED DIARRHEA AND INTESTINAL MUCOSITIS? EXPERIMENTAL STUDY IN THE RAT. NEUROGASTROENTEROL MOTIL. 2016.

  • MUKAIDA K, HATTORI N, IWAMOTO H, ET AL. MUSTARD GAS EXPOSURE AND MORTALITY AMONG RETIRED WORKERS AT A POISONOUS GAS FACTORY IN JAPAN: A 57-YEAR FOLLOW- UP COHORT STUDY. OCCUP ENVIRON MED. 2016.

    • Radiation causes Cancer

  • BUTCHER HR, SEAMAN WB, ECKERT C, SALTZSTEIN S. AN ASSESSMENT OF RADICAL MASTECTOMY AND POSTOPERATIVE IRRADIATION THERAPY IN THE TREATMENT OF MAMMARY CANCER. CANCER. 1964;17:480-5.

  • CANTREL, S. T. AND BUSCHKE, F.: THE ROLE OF ROENTGEN THERAPY IN CARCINOMA OF THE BREAST. WEST. J. SURG. OBSTET. GYNEC. 54: 369, 1946.

  • CHU FC, LUCAS JC, FARROW JH, NICKSON JJ. DOES PROPHYLACTIC RADIATION THERAPY GIVEN FOR CANCER OF THE BREAST PREDISPOSE TO METASTASIS?. AM J ROENTGENOL RADIUM THER NUCL MED. 1967;99(4):987-94.

  • EASSON, E. C.: POSTOPERATIVE RADIOTHERAPY IN BREAST CANCER IN SYMPOSIUM ON PROGNOSTIC FACTORS IN BREAST CANCER. (EDINBURGH: LIVINGSTON, 1968), PP. 118-127.

  • HAAGENSEN, C. D. AND STOUT, A. P.: CARCINOMA OF THE BREAST. I. RESULTS OF TREATMENT. ANN. SURG,, 116:801, 1942.

  • ELKINS HB, HICKEY RC, KERR HD, TIDRICK RT, WIEBEN EE. CANCER OF THE BREAST, 1661 PATIENTS. 1. CONSIDERATIONS IN FUTURE THERAPY. AMA ARCH SURG. 1956;73(4):654-60.

  • PATERSON, RALSTON, AND MARION H. RUSSELL. "CLINICAL TRIALS IN MALIGNANT DISEASE." JOURNAL OF THE FACULTY OF RADIOLOGISTS 10.4 (1959): 175-180.

  • ROBBINS GF, LUCAS JC, FRACCHIA AA, FARROW JH, CHU FC. AN EVALUATION OF POSTOPERATIVE PROPHYLACTIC RADIATION THERAPY IN BREAST CANCER. SURG GYNECOL OBSTET. 1966;122(5):979- 82.

  • TREVES N, HOLLEB AL. A REPORT OF 549 CASES OF BREAST CANCER IN WOMEN 35 YEARS OF AGE OR YOUNGER, SURG GYNECOL OBSTET. 1958;107(3):271-83.

  • DAO, T. L. AND KOVARIC, J.: INCIDENCE OF PULMONARY AND SKIN METASTASES IN WOMEN WITH BREAST CANCER WHO RECEIVED POSTOPERATIVE IRRADIATION. SURGERY, 52:203, 1962.

  • DECOURMELLES, F.: ACTION ATROPHIQUE GLANDULAIRE DES RAYONS X. C. R. ACAD. SCI (PARIS), 140:606, 1905.

  • FISHER B, SLACK NH, CAVANAUGH PJ, GARDNER B, RAVDIN RG. POSTOPERATIVE RADIOTHERAPY IN THE TREATMENT OF BREAST CANCER: RESULTS OF THE NSABP CLINICAL TRIAL. ANN SURG. 1970;172(4):711-32.

  • STJERNSWÄRD J. DECREASED SURVIVAL RELATED TO IRRADIATION POSTOPERATIVELY IN EARLY OPERABLE BREAST CANCER, LANCET. 1974;2(7892):1285-6.

  • EFFECTS OF RADIOTHERAPY AND SURGERY IN EARLY BREAST CANCER. AN OVERVIEW OF THE RANDOMIZED TRIALS. EARLY BREAST CANCER TRIALISTS' COLLABORATIVE GROUP. N ENGL J MED. 1995;333(22):1444-55.

  • POSTOPERATIVE RADIOTHERAPY IN NON-SMALL-CELL LUNG CANCER: SYSTEMATIC REVIEW AND META-ANALYSIS OF INDIVIDUAL PATIENT DATA FROM NINE RANDOMISED CONTROLLED TRIALS. PORT META-ANALYSIS TRIALISTS GROUP, LANCET. 1998;352(9124):257-63.

  • BURDETT S, STEWART L. POSTOPERATIVE RADIOTHERAPY IN NON-SMALL-CELL LUNG CANCER: UPDATE OF AN INDIVIDUAL PATIENT DATA META-ANALYSIS. LUNG CANCER. 2005;47(1):81-3.

    • For more information, read the book

                                                        Click the book to read